PRQR - ProQR Therapeutics BV - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PRQR is currently covered by 4 analysts with an average price target of $6.33. This is a potential upside of $4.66 (279.04%) from yesterday's end of day stock price of $1.67.

ProQR Therapeutics BV's activity chart (see below) currently has 58 price targets and 75 ratings on display. The stock rating distribution of PRQR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 19.92% with an average time for these price targets to be met of 104.63 days.

Highest price target for PRQR is $10, Lowest price target is $3, average price target is $6.33.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL. First documented stock forecast 26-Sep-2017.

Currently out of the existing stock ratings of PRQR, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2025

$6

$4.36 (265.85%)

$5

3 months 7 days ago
(29-Jun-2026)

0/2 (0%)

$4.17 (227.87%)

Buy Since 11-Feb-2025

$10

$8.36 (509.76%)

$11

3 months 10 days ago
(26-Jun-2026)

0/2 (0%)

$8.47 (553.59%)

Buy Since 30-Mar-2023

$8

$6.47 (422.88%)

$8

11 months 21 days ago
(15-Oct-2025)

0/7 (0%)

$5.29 (195.20%)

Buy Since 23-Dec-2022

$8

$6.47 (422.88%)

$8

1 years 2 months 19 days ago
(17-Jul-2025)

0/5 (0%)

$5.6 (233.33%)

Show more analysts

Please expand the browser size to see the chart

What is PRQR (ProQR Therapeutics BV) average time for price targets to be met?

On average it took 105 days for the stock forecasts to be reached, with an average price target met ratio of 19.92%.

Which analyst most recently updated their price target on PRQR (ProQR Therapeutics BV)?

Keay Nakae

Which analyst has the most public recommendations on PRQR (ProQR Therapeutics BV)?

Keay Nakae works at CHARDAN CAPITAL and has 7 price targets and 6 ratings on PRQR

Which analyst is the currently most bullish on PRQR (ProQR Therapeutics BV)?

Eliana Merle with the highest potential upside of $38.36

Which analyst is the currently most reserved on PRQR (ProQR Therapeutics BV)?

Keay Nakae with the lowest potential downside of $1.36
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?